Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET

L FardeG Sedvall


D2 dopamine receptors in the putamen of living human subjects were characterized by using the selective, high-affinity D2 dopamine receptor antagonist carbon-11-labeled raclopride and positron emission tomography. Experiments in four healthy men demonstrated saturability of [11C]raclopride binding to an apparently homogeneous population of sites with Hill coefficients close to unity. In the normal putamen, maximum binding ranged from 12 to 17 picomoles per cubic centimeter and dissociation constants from 3.4 to 4.7 nanomolar. Maximum binding for human putamen at autopsy was 15 picomoles per cubic centimeter. Studies of [11C]raclopride binding indicate that clinically effective doses of chemically distinct neuroleptic drugs result in 85 to 90 percent occupancy of D2 dopamine receptors in the putamen of schizophrenic patients.


Oct 31, 2002·Human Psychopharmacology·Alain Patat
Dec 1, 1990·Journal of Neurology·G V Sawle, D J Brooks
Jan 1, 1990·European Journal of Nuclear Medicine·B Mazière, M Mazière
Jan 1, 1990·European Journal of Nuclear Medicine·G BlomqvistC Halldin
Sep 1, 1991·Neurochemical Research·M E Phelps
Jan 1, 1991·Journal of Neural Transmission. General Section·O InoueB Langstrom
Jul 1, 1995·European Journal of Nuclear Medicine·G BlomqvistK Wienhard
Jan 1, 1994·European Archives of Psychiatry and Clinical Neuroscience·G SedvallL Farde
Jan 1, 1991·European Journal of Nuclear Medicine·J T KuikkaL E Feinendegen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.